<?xml version="1.0" encoding="UTF-8"?>
<p>AAV is a single-stranded DNA, non-pathogenic, replication defective virus from the parvovirus family 
 <sup>
  <xref rid="ref-92" ref-type="bibr">92</xref>, 
  <xref rid="ref-95" ref-type="bibr">95</xref>
 </sup>. AAV vectors have a package capacity of 4.7 kb, which easily can accommodate FIX cDNA (approximately 1.6 kb) 
 <sup>
  <xref rid="ref-96" ref-type="bibr">96</xref>
 </sup> but was initially challenging for FVIII cDNA (7 kb) even after the removal of the B-domain (BDD, approximately 40% of the gene, 4.4 kb) that is not required for coagulation function 
 <sup>
  <xref rid="ref-97" ref-type="bibr">97</xref>
 </sup>. Consequently, AAV-based gene therapy strategies were initially focused on HB, despite the fact that it is the least common form of hemophilia.
</p>
